Pharmalytica Services

Leadership Team

Our leadership team is comprised of representatives from the core areas of strategic development, technical & regulatory development, laboratory operations and marketing. Leadership team members are dedicated to providing our clients with expert services at the highest level of quality in the industry. Team members are also committed to providing the employees of Pharmalytica Services with a rewarding growth environment that is both challenging and fun.

	James R. Scull, Ph.D. Executive Director and Managing Member
	Richard C. Wedlich, M.S. Vice President, Quality Assurance
	David Z. Chen, Ph.D. Vice President, R & D
	Daniel F. Giordano Vice President, Laboratory Operations

Team member biographies are provided below.

James R. Scull, PhD
Executive Director and Managing Member
Dr. James Scull has more than 22 years of pharmaceutical development experience spanning all areas from discovery support to Phase III clinical trials. His current responsibilities include providing strategic scientific and technical leadership with a global perspective. Dr. Scull is focused on providing clients with technical expertise and project management designed to accelerate the drug development process. Dr. Scull's primary expertise is in the areas of GLP analytical chemistry, formulation, compliance and separation science. He also leads our efforts of global expansion and is an expert in conducting toxicology studies internationally. Dr. Scull also serves as a member of the editorial advisory board of Contract Pharma Magazine and is a member of the American Association of Pharmaceutical Scientists (AAPS). Prior to joining Pharmalytica Services, Dr. Scull served as a Principal Research Scientist for the DuPont Pharmaceutical Company and GLP Outsourcing Manager for Purdue Pharma. Dr. Scull holds a PhD in Analytical Chemistry from Villanova University and a BS in Chemistry from Widener University.

Richard C. Wedlich, M.S.
Vice President, Quality Assurance
Mr. Richard C. Wedlich has more than 24 years R&D experience in the pharmaceutical, chemical and aerospace industries. He is Vice President, Quality Assurance for Pharmalytica Services. Prior to joining Pharmalytica, he was Senior Process Engineer in the chemical development department of the Schering-Plough Research Institute, Senior Process Safety Engineer for Chilworth Technology, Senior Research Chemist for Olin Corporation and Research Scientist for Lockheed Engineering. Mr. Wedlich's expertise in GLP/GMP compliance started in the late 1980s when he was appointed as GLP Study Director at Olin Corporation (now ARCH Chemicals, Inc.) supporting biocide and pesticide EPA registrations. He is co-author of the NASA Hydrazine Handbook and has published numerous articles and given many podium presentations in his fields of expertise. Mr. Wedlich holds a BS in Chemistry from Ramapo College and an MS in Physical Chemistry from Marquette University.

David Z. Chen, Ph.D.
Vice President, R & D
Dr. David Chen has more than 20 years of pharmaceutical development experience in the areas of process analytical technology, solid state characterization of drug substance and drug product, chemcial process development and manufacturing support. His current responsibilities include leading the analytical and bioanalysis groups and oversight of all technical operations for Pharmalytica Services. In addition, Dr. Chen also serves as a Senior Client Consultant on solid state characterization, polymorph determination and process analytical technology. Prior to joining Pharmalytica Services, Dr. Chen served as Manager for Schering-Plough Global Quality and as a Research Leader for Roche Pharmaceuticals. Dr. Chen holds a PhD in Physical Chemistry from the University of Miami and a BS in Chemistry from Wuhan University in China.

Daniel F. Giordano
Vice President, Laboratory Operations
Mr. Daniel F. Giordano is presently Vice President, Laboratory Operations for Pharmalytica Services. Prior to joining Pharmalytica, Mr. Giordano was a Research Chemist at Olin Corporation (presently known as ARCH Chemicals) where he was employed for 35 years. His area of expertise is in chromatography and especially, gas chromatography. At Olin, he developed numerous analytical methods and developed many SOPs under GLP, while supporting Olin's effort to register new pesticides and biocides with the EPA. He is a member of the Connecticut Separations Science Counsel.